Ask us anything.Need assistance with your custom assay design? Let us know how we can help. Fluidigm respects your privacy. |
Fluidigm continues to team up with researchers around the world who are working to mount an aggressive and sustainable response to the COVID-19 pandemic. Below are publications, posters, recorded webinars and seminars with presentations and other resources relevant to COVID-19 research. To see a complete summary of more than 50 publications using CyTOF technology to research COVID-19, download the full list. Recent publications: This issue of the quarterly anthology focuses on publications using mass cytometry to characterize and comprehend COVID-19 disease. See how researchers are making rapid discoveries about disease pathology and integrating immune monitoring with CyTOF® into clinical research trials to decipher the immune response to infection. A Multi-Omic Approach to Detection and Characterization of Viral Pathogens and Their Impact on the Immune System Andrew Quong, PhD Chief Science Officer Bill Hunt, MS Director, Microfluidics Product Management Detection of Human and Viral Full-Length RNA Using a Nanoscale Microfluidic Platform Steve Kain, PhD, MBA Director, Genomics Product Management |